louise.bellamy@pharmaphorum.com, Author at

How healthcare professionals (HCPs) prefer to engage with pharma companies has been changing for some time, and COVID’s

Customer engagement and pharma’s field force future

https://pharmaphorum.com/webinars/axtria-customer-engagement-pharmas-field-force-future-digital-transformation/

SAVANA_webinar_holding_slide-23.03.21-1200x675

Debates & Insights/ R&D/ Views & Analysis/ Views and analysis/ Webinars/ Webinars On demand

AI, big data and deep real-world evidence – the challenges and opportunities

louise.bellamy@pharmaphorum.com AI, big data, BREATHE data research hub, clinical trials, Real World Evidence, RWE, Savana 0 Comment

Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights

AI, big data and deep real-world evidence – the challenges and opportunities

https://pharmaphorum.com/webinars/ai-big-data-real-world-evidence-savana/

Debates & Insights/ R&D/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

Virtual trials and the next generation of pharma clinical research

louise.bellamy@pharmaphorum.com clinical trials, COVID-19, decentralised trials, NIHR, patient access, virtual trials 0 Comment

Previously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a

Virtual trials and the next generation of pharma clinical research

https://pharmaphorum.com/webinars/nihr-virtual-trials-pharma-research/

Partner content/ Press releases

First Psychiatry Consortium funded project announced for schizophrenia

louise.bellamy@pharmaphorum.com medicines discovery catapult, Psychiatry Consortium, schizophrenia 0 Comment

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer

First Psychiatry Consortium funded project announced for schizophrenia

https://pharmaphorum.com/partner-content/first-psychiatry-consortium-funded-project-announced-for-schizophrenia/

Debates & Insights/ R&D/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

Coordinating and delivering research in the pandemic: The UK approach

louise.bellamy@pharmaphorum.com clinical research, clinical trial regulation, clinical trials, coronavirus, COVID-19, NIHR, trial recruitment 0 Comment

The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical

Coordinating and delivering research in the pandemic: The UK approach

https://pharmaphorum.com/webinars/uk-covid-coronavirus-research-nihr/

(781)NIHR-2nd-Webinar-Image-16x9-Text-v3

Debates & Insights/ R&D/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

Increasing patient engagement with UK clinical trials

louise.bellamy@pharmaphorum.com clinical trials, compliance, NHS, NIHR, patient engagement, Regulatory affairs, regulatory frameworks 0 Comment

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so

Increasing patient engagement with UK clinical trials

https://pharmaphorum.com/webinars/uk-regulatory-pathway-patient-engagement-trials/

Debates & Insights/ R&D/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

Introducing the new NIHR National Patient Recruitment Centres

louise.bellamy@pharmaphorum.com access to clinical trials, clinical trials, NHS, NIHR, virtual trials 0 Comment

The five new NIHR National Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical

Introducing the new NIHR National Patient Recruitment Centres

https://pharmaphorum.com/webinars/nihr-national-patient-recruitment-centres/

Debates/ Oncology/ Webinars/ Webinars in home page/ Webinars On demand

Clinical decision-making insights for haem/oncs

louise.bellamy@pharmaphorum.com clinical decision-making, CME, continuing medical education, haem-onc, haemato-oncologists, haemato-oncology, haematologists, Haematology, oncologists, Oncology 0 Comment

Despite the effects of countries’ lockdown policies, a plethora of clinical trial readouts continue to emerge providing several

Clinical decision-making insights for haem/oncs

https://pharmaphorum.com/oncology/clinical-decision-making-insights-haem-oncs/

Debates/ Digital/ Webinars/ Webinars On demand

How to win with a multichannel approach in pharma

louise.bellamy@pharmaphorum.com customer journey, marketing automation, Modular content, multichannel marketing, omnichannel marketing, Viseven 0 Comment

A multichannel marketing approach, together with compelling content, is the ultimate way for pharma to deliver the message

How to win with a multichannel approach in pharma

https://pharmaphorum.com/digital/multichannel-approach-pharma-viseven/

Trending

About Louise Bellamy

Posts by Louise Bellamy:

Customer engagement and pharma’s field force future

AI, big data and deep real-world evidence – the challenges and opportunities

Virtual trials and the next generation of pharma clinical research

First Psychiatry Consortium funded project announced for schizophrenia

Coordinating and delivering research in the pandemic: The UK approach

Increasing patient engagement with UK clinical trials

Introducing the new NIHR National Patient Recruitment Centres

Clinical decision-making insights for haem/oncs

How to win with a multichannel approach in pharma

Trending

About Louise Bellamy

Posts by Louise Bellamy:

Login